JAZZ PHARMACEUTICALS FRANCE

🇫🇷France

Country: 🇫🇷France

Ownership: -

Established: 2003-01-01

Employees: -

Market Cap: -

Website: https://www.jazzpharma.com/careers/open-positions/

Clinical Trials

A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Phase 3

Completed

Conditions: Narcolepsy With Cataplexy

Interventions: Drug: JZP-258
Other: Placebo

First Posted Date: 2017-01-25

Last Posted Date: 2020-11-12

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 201

Registration Number: NCT03030599

Locations: 🇺🇸
SDS Clinical Trials, Inc., Orange, California, United States
🇺🇸
Stanford Health Services, Stanford, California, United States
🇺🇸
Fort Wayne Neurological Center, Fort Wayne, Indiana, United States

and more 22 locations

Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)

Phase 3

Completed

Conditions: Infantile Spasms

Interventions: Drug: GWP42003-P

First Posted Date: 2016-11-04

Last Posted Date: 2022-09-02

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 9

Registration Number: NCT02954887

Locations: 🇺🇸
Le Bonheur Children's Hospital, Memphis, Tennessee, United States
🇵🇱
Centrum Medyczne POMOC, Łódź, Poland
🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States

and more 4 locations

Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)

Phase 3

Completed

Conditions: Infantile Spasms

Interventions: Drug: GWP42003-P

First Posted Date: 2016-11-02

Last Posted Date: 2022-09-02

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 9

Registration Number: NCT02953548

Locations: 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸
The Childrens Hospital of San Antonio, San Antonio, Texas, United States

and more 5 locations

Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers

Phase 1

Completed

Conditions: HER2-expressing Cancers

Interventions: Drug: ZW25 (Zanidatamab)
Drug: Paclitaxel
Drug: Capecitabine
Drug: Vinorelbine
Drug: Tucatinib

First Posted Date: 2016-09-08

Last Posted Date: 2024-11-27

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 279

Registration Number: NCT02892123

Locations: 🇺🇸
Hoag Family Cancer Institute, Newport Beach, California, United States
🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

and more 14 locations

Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients

Phase 3

Completed

Conditions: Veno-occlusive Disease

Interventions: Other: Best Supportive Care
Drug: Defibrotide

First Posted Date: 2016-08-01

Last Posted Date: 2022-03-02

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 372

Registration Number: NCT02851407

Locations: 🇯🇵
Osaka City University Hospital, Osaka, Japan
🇯🇵
Medical Hospital Tokyo Medical and Dental University, Tokyo, Japan
🇰🇷
Severance Hospital at Yonsei University Health System, Seoul, Korea, Republic of

and more 111 locations

Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy

Phase 2

Completed

Conditions: Excessive Sleepiness
Narcolepsy

Interventions: Drug: Placebo
Drug: JZP-110

First Posted Date: 2016-06-21

Last Posted Date: 2021-01-13

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 24

Registration Number: NCT02806908

Locations: 🇳🇱
Maastricht University, Maastricht, Limburg, Netherlands

Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA

Phase 2

Completed

Conditions: Excessive Sleepiness
Obstructive Sleep Apnea

Interventions: Drug: JZP-110
Drug: Placebo

First Posted Date: 2016-06-21

Last Posted Date: 2021-01-14

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 34

Registration Number: NCT02806895

Locations: 🇳🇱
Maastricht University, Maastricht, Limburg, Netherlands

A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy

Completed

Conditions: Narcolepsy

First Posted Date: 2016-05-12

Last Posted Date: 2022-04-05

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 1500

Registration Number: NCT02769780

Locations: 🇺🇸
Jazz Pharmaceuticals, Palo Alto, California, United States

A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

Phase 2

Completed

Conditions: Epilepsy

Interventions: Drug: Placebo
Drug: GWP42003-P

First Posted Date: 2015-11-18

Last Posted Date: 2022-12-20

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 35

Registration Number: NCT02607891

Locations: 🇪🇸
Hospital Universitari Vall d'Hebron, Barcelona, Spain
🇳🇱
SEIN - Epilepsy Institute in the Netherlands Foundation, Zwolle, Netherlands
🇪🇸
Hospital Ruber Internacional, Madrid, Spain

and more 2 locations

An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

Phase 2

Completed

Conditions: Epilepsy

Interventions: Drug: GWP42003-P

First Posted Date: 2015-11-18

Last Posted Date: 2022-12-20

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 30

Registration Number: NCT02607904

Locations: 🇪🇸
Hospital Ruber Internacional, Madrid, Spain
🇪🇸
Hospital Universitario Virgen del Rocio, Sevilla, Spain
🇳🇱
SEIN - Epilepsy Institute in the Netherlands Foundation, Zwolle, Netherlands

and more 2 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy